Matches in Nanopublications for { ?s ?p "[The FISH assay detected intronic deletions between ERG and TMPRSS2 resulting in TMPRSS2:ERG fusion in 60.3% (35 of 58) of the primary TMPRSS2:ERG prostate cancers and 42.9% (3 of 7) of the TMPRSS2:ERG hormone-naive lymph node metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- assertion description "[The FISH assay detected intronic deletions between ERG and TMPRSS2 resulting in TMPRSS2:ERG fusion in 60.3% (35 of 58) of the primary TMPRSS2:ERG prostate cancers and 42.9% (3 of 7) of the TMPRSS2:ERG hormone-naive lymph node metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP383246.RAb2kpZCXYkam-Xw6NdIjtrcSczsYtcf_3QfcK-fgVPP0130_assertion description "[The FISH assay detected intronic deletions between ERG and TMPRSS2 resulting in TMPRSS2:ERG fusion in 60.3% (35 of 58) of the primary TMPRSS2:ERG prostate cancers and 42.9% (3 of 7) of the TMPRSS2:ERG hormone-naive lymph node metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP383246.RAb2kpZCXYkam-Xw6NdIjtrcSczsYtcf_3QfcK-fgVPP0130_provenance.
- NP522083.RAeIgWnl9fkvbYs17yP9apT9QLsPSJatzxz0CoZZ6cGXM130_assertion description "[The FISH assay detected intronic deletions between ERG and TMPRSS2 resulting in TMPRSS2:ERG fusion in 60.3% (35 of 58) of the primary TMPRSS2:ERG prostate cancers and 42.9% (3 of 7) of the TMPRSS2:ERG hormone-naive lymph node metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP522083.RAeIgWnl9fkvbYs17yP9apT9QLsPSJatzxz0CoZZ6cGXM130_provenance.
- assertion description "[The FISH assay detected intronic deletions between ERG and TMPRSS2 resulting in TMPRSS2:ERG fusion in 60.3% (35 of 58) of the primary TMPRSS2:ERG prostate cancers and 42.9% (3 of 7) of the TMPRSS2:ERG hormone-naive lymph node metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP567389.RAaclra3Y27rXBiNb9K8NWWfX-ffCDpuE4I3N_DeNPd-U130_assertion description "[The FISH assay detected intronic deletions between ERG and TMPRSS2 resulting in TMPRSS2:ERG fusion in 60.3% (35 of 58) of the primary TMPRSS2:ERG prostate cancers and 42.9% (3 of 7) of the TMPRSS2:ERG hormone-naive lymph node metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP567389.RAaclra3Y27rXBiNb9K8NWWfX-ffCDpuE4I3N_DeNPd-U130_provenance.
- NP567391.RAZybSJFQpJc9yLfa0C45bRuXQK68rnNUh1vGRPNysJGc130_assertion description "[The FISH assay detected intronic deletions between ERG and TMPRSS2 resulting in TMPRSS2:ERG fusion in 60.3% (35 of 58) of the primary TMPRSS2:ERG prostate cancers and 42.9% (3 of 7) of the TMPRSS2:ERG hormone-naive lymph node metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP567391.RAZybSJFQpJc9yLfa0C45bRuXQK68rnNUh1vGRPNysJGc130_provenance.
- NP567394.RAbeLz1FNJHJCst0R3HfLxEMmx4PGRXiL8IaPht3uYs2M130_assertion description "[The FISH assay detected intronic deletions between ERG and TMPRSS2 resulting in TMPRSS2:ERG fusion in 60.3% (35 of 58) of the primary TMPRSS2:ERG prostate cancers and 42.9% (3 of 7) of the TMPRSS2:ERG hormone-naive lymph node metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP567394.RAbeLz1FNJHJCst0R3HfLxEMmx4PGRXiL8IaPht3uYs2M130_provenance.
- NP742872.RAqgHYzTq9jlR2V89uxiF_cj4BldKy6s50BReOUY0LGz4130_assertion description "[The FISH assay detected intronic deletions between ERG and TMPRSS2 resulting in TMPRSS2:ERG fusion in 60.3% (35 of 58) of the primary TMPRSS2:ERG prostate cancers and 42.9% (3 of 7) of the TMPRSS2:ERG hormone-naive lymph node metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP742872.RAqgHYzTq9jlR2V89uxiF_cj4BldKy6s50BReOUY0LGz4130_provenance.